Tubaro E - Search Results

1

Enhancement of lymphocyte proliferation and IL-2 receptor expression by a processed form (GM-1/P) of monosialoganglioside GM-1.

Giuffrida A, Morrone S, Gismondi A, Santoni G, Punturieri A, Velotti F, Cavallo G, Tubaro E, Piccoli M, Frati L, et al. Giuffrida A, et al. Among authors: tubaro e. Immunopharmacol Immunotoxicol. 1990;12(4):565-82. doi: 10.3109/08923979009019677. Immunopharmacol Immunotoxicol. 1990. PMID: 2092040

2

Augmentation of mouse natural killer (NK) activity by GM-1/P, a processed form of monosialoganglioside GM-1.

Giuffrida A, Galli MC, Gismondi A, Santoni G, Piccoli M, Cavallo G, Tubaro E, Frati L, Santoni A. Giuffrida A, et al. Among authors: tubaro e. Immunopharmacol Immunotoxicol. 1990;12(4):545-63. doi: 10.3109/08923979009019676. Immunopharmacol Immunotoxicol. 1990. PMID: 2092039

3

Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.

Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A. Cifone MG, et al. Among authors: tubaro e. Cell Immunol. 1994 Aug;157(1):181-94. doi: 10.1006/cimm.1994.1215. Cell Immunol. 1994. PMID: 7518750

4

Preparation and characterization of four new variously deacetylated lysogangliosides, breakdown products of GM1.

Cavallo G, Iavarone C, Tubaro E. Cavallo G, et al. Among authors: tubaro e. Carbohydr Res. 1993 Oct 4;248:251-65. doi: 10.1016/0008-6215(93)84132-p. Carbohydr Res. 1993. PMID: 8252537

5

Effect of a new de-N-acetyl-lysoglycosphingolipid on some tumour models.

Tubaro E, Borelli GP, Belogi L, Cavallo G, Santoni A, Mainiero F. Tubaro E, et al. Eur J Pharmacol. 1995 Dec 29;294(2-3):555-63. doi: 10.1016/0014-2999(95)00583-8. Eur J Pharmacol. 1995. PMID: 8750718

6

Antiplatelet effects of a new de-N-acetyl-lyso-glycosphingolipid.

Tubaro E, Belogi L, Croce C, Cavallo G, Guida G, Borelli GP. Tubaro E, et al. Eur J Pharmacol. 1993 Aug 2;248(2):175-83. doi: 10.1016/0926-6917(93)90040-w. Eur J Pharmacol. 1993. PMID: 8223963

7

Morphine and methadone impact on human phagocytic physiology.

Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G. Tubaro E, et al. Int J Immunopharmacol. 1985;7(6):865-74. doi: 10.1016/0192-0561(85)90049-9. Int J Immunopharmacol. 1985. PMID: 3000961

8

Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.

Tubaro E, Santiangeli C, Cavallo G, Belogi L, Guida G, Croce C, Modesti A. Tubaro E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):670-8. doi: 10.1007/BF00167246. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8133910

9

Methadone vs morphine: comparison of their effect on phagocytic functions.

Tubaro E, Santiangeli C, Belogi L, Borelli G, Cavallo G, Croce C, Avico U. Tubaro E, et al. Int J Immunopharmacol. 1987;9(1):79-88. doi: 10.1016/0192-0561(87)90113-5. Int J Immunopharmacol. 1987. PMID: 3034811

10

Increase of xanthine oxidase activity in infected mice: a second look by a specific assay method.

Tubaro E, Cavallo G, Santiangeli C. Tubaro E, et al. Biochem Pharmacol. 1982 Oct 1;31(19):3115. doi: 10.1016/0006-2952(82)90088-0. Biochem Pharmacol. 1982. PMID: 6897356 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters